Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Senior Appointments

30 Mar 2010 12:37

RNS Number : 4219J
W.H. Ireland Group PLC
30 March 2010
 



WH Ireland Group Plc

 

Appointment of New Heads of Institutional Sales/Trading and Corporate Finance

 

WH Ireland Group plc (AIM:WHI), the financial services group, is delighted to announce two senior appointments to lead its Institutional Sales/Trading and Corporate Finance operations. Both will be joining in the week commencing 12 April 2010.

 

Russell Hooper joins as Head of Institutional Sales/Trading and will be responsible for coordinating the Group's institutional stockbroking business. Previously, Russell has been Head of European Institutional Client Sales Trading and also Head of Pan European Hedge Fund Sales Trading at Merrill Lynch where he spent 15 years in the Institutional Equities division. He graduated in Materials Engineering from Cardiff University. His interests include cricket, rugby (Welsh) and cycling.

 

Chris Fielding joins as Head of Corporate Finance, bringing with him over 20 years' experience in corporate finance as a small/mid cap specialist. Since 2005, Chris has worked at Arden Partners, having previously spent eleven years at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse. Chris will be based in the Group's London office and will lead the continued expansion of the corporate finance business. Chris' interests and hobbies include rugby (English), skiing, classic cars, travel and walking.

 

The WH Ireland team already has significant depth of experience and strong regional coverage through John Wakefield (Bristol), Dan Bate (Manchester), James Joyce (London) and their respective teams, supported by the Group's award-winning research team, based in Leeds, headed by Matthew Davis. In line with the Group's strategy, these appointments will further enhance WH Ireland's institutional sales and corporate finance offering.

 

Commenting on the appointments, Richard Ford (CEO) said:

 

"We are delighted to have secured the services of two top calibre individuals both of whom bring substantial skill and experience to the firm. These appointments come at a time when we are seeing a significant uplift in client demand for our corporate stockbroking services where we are looking to build our already strong position in the market. Russell and Chris will continue to drive our business forward and complement our existing Securities business both in London and through our principal regional offices in Manchester, Leeds, Birmingham and Bristol."

 

John Wakefield commented:

 

"The two appointments continue the work already in place to address the aspirations of our corporate client base to gain wider access to sources of capital and to benefit from best of breed advice in our core small/mid cap market."

 

Matthew Davis (Head of Institutional Research) said of the appointments:

 

"Both Chris and Russell bring significant experience, further enhancing WH Ireland's distribution capability, both corporately and institutionally."

 

30 March 2010

 

Enquiries:

 

WH Ireland Tel: 020 7220 1666

Richard Ford

 

Biddicks (Financial PR to WH Ireland) Tel: 020 7448 1000

Zoe Biddick

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGFFMGDGGZM
Date   Source Headline
20th Sep 201810:35 amRNSHolding(s) in Company
31st Aug 20187:00 amRNSNotice of AGM
20th Aug 20188:49 amRNSIssue of Equity
26th Jul 201811:12 amRNSHolding(s) in Company
20th Jul 201811:51 amRNSShareholder Update - Directorate Change
20th Jul 201811:50 amRNSHolding(s) in Company
20th Jul 201811:50 amRNSHolding(s) in Company
20th Jul 201811:50 amRNSHolding(s) in Company
20th Jul 201811:50 amRNSHolding(s) in Company
19th Jul 20187:01 amRNSFinal Results - 16 Months Ended 31 March 2018
19th Jul 20187:00 amRNSDirectorate Change
17th May 20187:00 amRNSTrading Statement & Notice of Final Results
16th Feb 20184:54 pmRNSHolding(s) in Company
15th Feb 20184:06 pmRNSHolding(s) in Company
9th Feb 201810:18 amRNSResult of General Meeting
1st Feb 20189:58 amRNSIssue of Equity
29th Jan 20187:16 amRNSInterim Results - Replacement
23rd Jan 20187:00 amRNSPlacing & Notice of General Meeting
18th Dec 20173:15 pmRNSHolding(s) in Company
15th Dec 20177:00 amRNSTrading Statement
27th Nov 201711:09 amRNSIssue of Equity
17th Oct 20173:24 pmRNSAgreement
1st Aug 20171:10 pmRNSExercise of Options
24th Jul 20177:00 amRNSInterim Results for the Six Months end 31 May 2017
21st Jun 20177:00 amRNSTrading Update & Change of Accounting Ref Date
5th Jun 20177:00 amRNSWH Ireland Exchanges Contracts at One New Bailey
31st May 20177:00 amRNSPDMR Trading
30th May 20173:28 pmRNSNotification of Major Interest in Shares
26th May 201710:58 amRNSIssue of Equity
23rd May 20177:00 amRNSIssue of Equity
4th May 20177:00 amRNSPrivate Wealth Management Operational Changes
2nd May 201710:16 amRNSNotification of Major Interest in Shares
21st Apr 201710:52 amRNSHolding(s) in Company
12th Apr 20175:02 pmEQSIssue of Equity
30th Mar 20173:39 pmEQSResult of AGM
30th Mar 20177:00 amEQSAGM Statement
28th Mar 20175:00 pmRNSPDMR Trading
24th Mar 20179:21 amEQSW.H. Ireland Group PLC: Holding(s) in Company
14th Mar 201712:16 pmRNSAGM Update
1st Mar 20172:22 pmRNSHolding(s) in Company
27th Feb 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSNEW HEAD OF CORPORATE ADVISORY & BROKING
27th Jan 20176:00 amEQSW.H. Ireland Group PLC: Appointment of non-executive director
24th Jan 20177:00 amRNSSale of Freehold Property in Manchester
19th Dec 20167:00 amRNSTrading Update
8th Dec 20162:00 pmEQSHolding(s) in Company
1st Dec 20166:02 amEQSIssue of Equity
30th Nov 20166:00 amEQSCompletion of Placing
28th Nov 20167:00 amRNSDirectorate Change and Relationship Agreement
18th Oct 20163:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.